Valuation: Almirall, S.A.

Market Cap 2.42B 2.78B 2.25B 2.07B 3.9B 265B 3.96B 26.52B 10.41B 132B 10.44B 10.21B 443B P/E 2026 *
28.1x
P/E 2027 * 20.3x
Enterprise Value 2.31B 2.65B 2.15B 1.97B 3.72B 253B 3.78B 25.31B 9.93B 126B 9.97B 9.75B 423B EV / Sales 2026 *
1.88x
EV / Sales 2027 * 1.59x
Free-Float
35.93%
Yield 2026 *
1.83%
Yield 2027 * 1.89%
1 day-0.54%
1 week-1.95%
Current month-0.54%
1 month-3.16%
3 months-10.39%
6 months-14.02%
Current year-14.02%
1 week 10.98
Extreme 10.98
11.84
1 month 10.52
Extreme 10.52
11.96
Current year 10.52
Extreme 10.52
13.98
1 year 10.06
Extreme 10.06
13.98
3 years 7.85
Extreme 7.85
13.98
5 years 7.16
Extreme 7.16
14.96
10 years 7.16
Extreme 7.16
18.5
Manager TitleAgeSince
Chief Executive Officer - 2022-11-01
Director of Finance/CFO 53 2025-08-30
Chief Tech/Sci/R&D Officer - 2021-07-06
Director TitleAgeSince
Director/Board Member - 2013-12-31
Director/Board Member - 2015-12-31
Chairman - 2022-05-05
Date Insider Type Main position Quantity % Market Cap.
6/23/23 Buy

Executive/Senior Manager

3,000 0.0017%
6/22/23 Buy 4,340 0.0024%
6/22/23 Buy

Executive/Senior Manager

5,000 0.0028%
Change 5-day change 1-year change 3-year change Capi.($)
-0.54%-1.95%+7.18%+28.37% 2.78B
-0.53%-3.95%+50.70%+152.78% 1,024B
+0.21%-2.68%+53.20%+50.87% 618B
-2.51%-3.25%+28.54%+67.99% 443B
+1.19%-0.89%+39.96%+33.70% 349B
-0.05%-1.40%+33.98%+42.29% 297B
-6.06%-8.23%+6.21%+8.51% 264B
-0.25%-6.54%-2.51%-43.14% 209B
-0.64%+2.43%+29.74%+67.16% 208B
-0.82%+0.70%+15.05%+72.05% 162B
Average -1.00%-1.30%+26.21%+48.06% 357.65B
Weighted average by Cap. -0.85%-2.16%+36.70%+73.07%

Financials

2026 *2027 *
Net sales 1.23B 1.41B 1.14B 1.05B 1.98B 135B 2.02B 13.49B 5.29B 67.22B 5.31B 5.2B 225B 1.36B 1.56B 1.26B 1.16B 2.19B 149B 2.22B 14.88B 5.84B 74.15B 5.86B 5.73B 249B
Net income 84.14M 96.79M 78.32M 71.91M 136M 9.24B 138M 923M 362M 4.6B 364M 356M 15.42B 116M 134M 108M 99.45M 188M 12.78B 191M 1.28B 501M 6.36B 503M 492M 21.33B
Net Debt -111M -127M -103M -94.45M -178M -12.14B -181M -1.21B -476M -6.04B -477M -467M -20.26B -255M -293M -237M -218M -412M -28.01B -418M -2.8B -1.1B -13.94B -1.1B -1.08B -46.76B
Logo Almirall, S.A.
Almirall SA is a Spain-based company principally engaged in the pharmaceuticals manufacture. The Company focuses on development and marketing of drugs applied in various therapeutic areas, such as nervous system, gastrointestinal, dermatological, respiratory system, antiinfectives, as well as antineoplastic and immunomodulating agents. The Company's activities are divided into four business segments: Own network, which focuses on the commercialization of pharmaceuticals through own brand names; Licenses, which sells product rights to third parties; Research and development (R&D), which is responsible for the creation of drug candidates, as well as Dermatology, which includes sale of dermatological medicines in the United States. The Company operates through numerous subsidiaries in Europe, the Americas, Africa, Asia and Australia.
Employees
2,097
Date Price Change Volume
26-08-03 11.00 -0.90% 28,993
26-07-31 €11.10 -1.07% 127,551
26-07-30 €11.22 -2.09% 119,627
26-07-29 €11.46 -1.72% 100,337
26-07-28 €11.66 +3.55% 168,665
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
11.10EUR
Average target price
14.51EUR
Spread / Average Target
+30.71%

Quarterly revenue - Rate of surprise